Antimicrobial use and susceptibility rates in isolates from intensive care unit and other nosocomial inpatient and outpatient areas

New Microbiologica

Volumn 24, Issue 1, 2001, Pages 47-56

  Lang, A ^a   De Fina, G ^a   Meyer, R ^a   Aschbacher, R ^a   Zelger, P ^a   Paluselli, P ^a   Rizza, F ^a  

^a NONE

Author keywords

Antimicrobial use and susceptibility; Gram negative bacteria; Gram positive bacteria; Intensive care

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; MONOBACTAM DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; COMPARATIVE STUDY; CROSS INFECTION; DISEASE PREDISPOSITION; DRUG EFFECT; ENTEROCOCCUS; ESCHERICHIA COLI; HUMAN; INTENSIVE CARE UNIT; MICROBIOLOGY; OUTPATIENT DEPARTMENT; PREVALENCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

AMBULATORY CARE FACILITIES; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CARBAPENEMS; CEPHALOSPORINS; CROSS INFECTION; DISEASE SUSCEPTIBILITY; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; ESCHERICHIA COLI; HUMANS; INTENSIVE CARE UNITS; MONOBACTAMS; PREVALENCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 0035228820     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. ARCHIBALD, L.K., PHILLIPS, L., MONNET, D., MCGOWAN, J.E.JR., TENOVER, F., and GAYNES R., (1997). Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit. Clinical Infectious Diseases, 24, 211-215.
2. BERT, F., and YECHOVSKY, L. (1996). Comparative distribution of resistance patterns and serotypes in Pseudomonas aeruginosa isolates from intensive care units and other wards. Journal of Antimicrobial Chemotherapy, 37, 809-813.
3. BOYCE, J.M. (1998). Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing? Journal of the American Medical Association, 279, 623-624.
4. BRYCE, E.A., and SMITH, J.A. (1995). Focused microbiological surveillance and gram-negative beta-lactamase-mediated resistance in the intensive care unit. Infection Control and Hospital Epidemiology, 16, 331-334.
5. D'AGATA, E., VENKATARAMAN, L., DE GIROLAMI, P., BURKE, P., ELIOPOULOS, G.M., KARCHMER, A.W., and SAMORE, M.H. (1999). Colonization with broad-spectrum cephalosporin-resistant Gram-negative bacilli in intensive care units during a nonoutbreak period: Prevalence, risk factors, and rate of infection. Critical Care Medicine, 27, 1090-1095.
6. DONOWITZ, L.G., WENZEL, R.P., and HOYT, J.W. (1982). High risk of hospital-acquired infections in the ICU patient. Critical Care Medicine, 10, 355-357.
7. EICKHOFF, T.C. (1992). Antibiotics and nosocomial infections. In: Bennett J.V., Brachman P.S., eds. Hospital infections. Boston: Little, Brown & Co., 245-264.
8. FLAHERTY, J.P., and WEINSTEIN, R.A. (1996). Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit. Infection Control and Hospital Epidemiology, 17, 236-248.
9. FRIDKIN, S.K., STEWARD, C.D., EDWARDS, J.R., PRYOR, E.R., MCGOWAN, J.E.JR., ARCHIBALD, L.K., GAYNES, R.P., and TENOVER, F.C. (1999). Surveillance of Antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance epidemiology (ICARE) hospitals. Clinical Infectious Diseases, 29, 245-252.
10. JARVIS, W.R., EDWARDS, J.R., and CULVER, D.H. (1991). Nosocomial infection rates in adult and pediatric intensive care units in the United States. American Journal of Medicine, 91 (suppl. 3B), 185-191.
11. MCGOWAN, J.E.JR., HALL, E.C., and PARROTT, P.L. (1989). Antimicrobial susceptibility in Gram-negative bacteremia: are nosocomial isolates really more resistant? Antimicrobial Agents and Chemotherapy, 33, 1855-1859.
12. MONNET, D.L., ARCHIBALD, L.K., PHILLIPS, L., TENOVER, F.C., MCGOWAN, J.E.JR., and GAYNES (1998). Antimicrobial Use and Resistance in eight US Hospitals: Complexities of Analysis and Modelling. Infection Control and Hospital Epididemiology, 19, 388-394.
13. PENA, C., PUJOL, M., and ARDANUY, C. (1998). Epidemiology and succsessful control of a large outbreak due to Klesiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrobial Agents and Chemotherapy, 42, 53-58.
14. REPERTORIO FARMACEUTICO ITALIANO (1999). Farmindustria. Associazione nazionale dell' industria farmaceutica. OVP Italia S.p.a.-C.so P.ta Romana 6, Milano.
15. TOLTZIS, P., YAMASHITA, T., VILT, L., and BLUMER, J.L. (1997). Colonization with antibiotic-resistant Gram-negative organisms in a pediatric intensive care unit. Critical Care Medicine, 25, 538-544.